138 related articles for article (PubMed ID: 34559472)
1. Wilson's Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States.
Rustgi VK; Gupta K; Tait C; Bhurwal A; Kabaria S; Catalano C; Li Y; Minacapelli CD
Hepatol Commun; 2022 Feb; 6(2):389-398. PubMed ID: 34559472
[TBL] [Abstract][Full Text] [Related]
2. Health Care Utilization and Economic Burdens of Hemochromatosis in the United States: A Population-Based Claims Study.
Elsaid MI; John T; Li Y; Koduru S; Ali SZ; Catalano C; Narayanan N; Rustgi VK
J Manag Care Spec Pharm; 2019 Dec; 25(12):1377-1386. PubMed ID: 31778618
[TBL] [Abstract][Full Text] [Related]
3. Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States.
Elsaid MI; Li Y; Catalano C; Minacapelli CD; Gupta K; Rustgi VK
Pharmacoecon Open; 2021 Mar; 5(1):89-100. PubMed ID: 32897528
[TBL] [Abstract][Full Text] [Related]
4. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
Buono JL; Mathur K; Averitt AJ; Andrae DA
J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
6. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
7. Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis.
Wallace A; Barron J; York W; Isenberg K; Franchino-Elder J; Sidovar M; Sand M
J Manag Care Spec Pharm; 2019 Oct; 25(10):1102-1110. PubMed ID: 31556820
[TBL] [Abstract][Full Text] [Related]
8. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
9. The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings.
Black J; Reaven NL; Funk SE; McGaughey K; Ohayon M; Guilleminault C; Ruoff C; Mignot E
Sleep Med; 2014 May; 15(5):522-9. PubMed ID: 24768358
[TBL] [Abstract][Full Text] [Related]
10. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases.
Fuldeore M; Yang H; Du EX; Soliman AM; Wu EQ; Winkel C
Fertil Steril; 2015 Jan; 103(1):163-71. PubMed ID: 25455535
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
[TBL] [Abstract][Full Text] [Related]
12. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic burden of breakthrough seizures.
Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
[TBL] [Abstract][Full Text] [Related]
14. Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis.
Cappell K; Taylor A; Johnson BH; Gelwicks S; Wang S; Gerber M; Leffler DA
Am J Gastroenterol; 2020 Nov; 115(11):1821-1829. PubMed ID: 33156101
[TBL] [Abstract][Full Text] [Related]
15. Health care resource utilization and medical costs of spinal cord injury with neuropathic pain in a commercially insured population in the United States.
Margolis JM; Juneau P; Sadosky A; Cappelleri JC; Bryce TN; Nieshoff EC
Arch Phys Med Rehabil; 2014 Dec; 95(12):2279-87. PubMed ID: 25159715
[TBL] [Abstract][Full Text] [Related]
16. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
17. Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA.
Bell CF; Priest J; Stott-Miller M; Kan H; Amelio J; Song X; Limone B; Noxon V; Costenbader KH
Lupus Sci Med; 2020; 7(1):e000357. PubMed ID: 32341790
[TBL] [Abstract][Full Text] [Related]
18. The cost implications of Wilson disease among hospitalized patients: analysis of USA hospitals.
Lee DU; Harmacinski A; Bahadur A; Lee KJ; Chou H; Shaik MR; Chou H; Fan GH; Kwon J; Ponder R; Chang K; Lee K; Lominadze Z
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):929-940. PubMed ID: 38652529
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
20. Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States.
Soliman AM; Surrey E; Bonafede M; Nelson JK; Castelli-Haley J
Adv Ther; 2018 Mar; 35(3):408-423. PubMed ID: 29450864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
